Skip to main content
A

AOTI, Inc. — Investor Relations & Filings

Ticker · AOTI ISIN · US03690C1027 LEI · 213800ZGCNDSTWIRK687 IL Manufacturing
Open in API
Filings indexed 44 across all filing types
Latest filing 2025-02-12 Earnings Release
Country US United States of America
Listing IL AOTI

About AOTI, Inc.

https://aotinc.net

AOTI, Inc. (Advanced Oxygen Therapy Inc.) is a medical technology company specializing in solutions for chronic non-healing and complex acute wounds. The company's primary product is the patented Topical Wound Oxygen (TWO2) therapy, a multi-modality system designed for patient use at home. This therapy combines high-pressure topical oxygen, non-contact cyclical compression, and controlled humidity to promote durable healing. It is primarily used for treating conditions such as Diabetic Foot Ulcers (DFUs) and venous leg ulcers. Clinical evidence demonstrates that TWO2 therapy effectively reduces amputations, hospitalizations, and wound recurrence, leading to improved patient outcomes and lower overall healthcare costs.

Recent filings

Filing Released Lang Actions
Trading Update for the year ended 31 December 2024
Earnings Release Classification · 1% confidence The document is an 'RNS' (Regulatory News Service) announcement from AOTI, Inc. titled 'Trading Update for the year ended 31 December 2024'. It provides unaudited financial highlights, such as revenue growth and adjusted EBITDA margins, ahead of the full audited report. This fits the definition of an 'Earnings Release' (ER), which is the initial announcement of periodic financial results containing key highlights. It is not a full report (10-K or IR) and is not merely an announcement of a report's publication (RPA), as it contains substantive financial data. FY 2024
2025-02-12 English
CORRECTION New Medicaid states, coverage expansion
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from AOTI, Inc. regarding a correction ('REPLACEMENT') to a previously released announcement about Medicaid states and payer coverage. It provides operational updates, market access progress, and forward-looking statements, but it is not a formal financial report (like a 10-K or IR) nor a standalone earnings release. As it is a regulatory announcement distributed via RNS, it falls under the 'RNS' category.
2025-01-24 English
New Medicaid states, payer coverage expansion
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from AOTI, Inc. regarding its market access and commercial expansion strategy. It provides operational updates, such as Medicaid state penetration and sales team growth, but explicitly states that a financial trading update for FY24 will be announced in mid-February and full-year results in April. Since this is a general corporate update/announcement distributed via a regulatory news service and does not fit into specific categories like 'Earnings Release' (as it is a strategic update) or 'Annual Report', it falls under the 'Regulatory Filings' (RNS) category.
2025-01-09 English
Grant of performance share awards under LTIP
Director's Dealing Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from AOTI, Inc. regarding the grant of performance share awards to the CFO, who is identified as a Person Discharging Managerial Responsibilities (PDMR). The text includes a detailed table of the transaction, the nature of the award under the Long Term Incentive Plan (LTIP), and the required PDMR notification fields. This falls under the category of Director's Dealing (DIRS), as it reports share-based compensation/transactions involving a company executive.
2024-12-17 English
Enrolment Commences for VLU Clinical Trial
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding AOTI, Inc. It details the commencement of patient enrollment for a clinical trial (VaLUe trial). Since this is a general corporate announcement regarding operational progress and does not fit into specific categories like financial results, M&A, or director dealings, it falls under the 'Regulatory Filings' category as a general corporate update.
2024-12-16 English
5 Year Veterans Administration Contract Extension
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces a specific business development: the extension of a contract with the U.S. Department of Veterans Affairs. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a general corporate announcement regarding business operations, it falls under the 'Regulatory Filings' (RNS) category.
2024-12-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.